Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB) disease. According to Gen Consulting Company, the global latent tuberculosis infection (LTBI) testing market size is expected to increase from USD 1,344 million in 2020 to USD 1,942 million by 2027, garnering a CAGR of 5.4% over the evaluated period.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global latent tuberculosis infection (LTBI) testing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the latent tuberculosis infection (LTBI) testing industry.
The latent tuberculosis infection (LTBI) testing market is segmented on the basis of type, end user, and region. The latent tuberculosis infection (LTBI) testing market is segmented as below:
By type:
– tuberculin skin test (TST)
– interferon gamma released assay (IGRA)
By end user:
– hospitals
– diagnostic centers
– laboratories
– others
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The market research report covers the analysis of key stake holders of the global latent tuberculosis infection (LTBI) testing market. Some of the leading players profiled in the report include Abbott Laboratories, ARKRAY, Inc., Becton, Dickinson and Company, bioMerieux S.A., Lionex Gmbh, Oxford Immunotec Global PLC, Qiagen N.V., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global latent tuberculosis infection (LTBI) testing market.
– To classify and forecast the global latent tuberculosis infection (LTBI) testing market based on type, end user, and region.
– To identify drivers and challenges for the global latent tuberculosis infection (LTBI) testing market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global latent tuberculosis infection (LTBI) testing market.
– To identify and analyze the profile of leading players operating in the global latent tuberculosis infection (LTBI) testing market.
Why Choose This Report
– Gain a reliable outlook of the global latent tuberculosis infection (LTBI) testing market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2020 |
| Forecast Year | 2021-2027 |
| CAGR (2021-2027) | 5.7% |
| Pages | 87 |
| Key Players | Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GMBH, Cardinal Health Inc., Coloplast A/S, ConvaTec Group plc, Medline Industries Inc., Mölnlycke Health Care AB., Organogenesis Inc., Smith & Nephew PLC, The 3M Company |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
